MADIA

News

Bioanalitica 2018

Bioanalitica 2018

Our project partner Scriba Nanotecnologie has presented MADIA project at Bioanalitica 2018 (Bologna, Italy). The Congress is organized yearly by the Analytical Chemistry Division of the Italian Chemical Society and it provides an opportunity for all researchers in the field to meet and debate key topics. The different aspects of Analytical Chemistry are covered, from the traditional sectors to the most innovative ones.

Read more


World Alzheimer’s Day

World Alzheimer’s Day

September 21st every year is World Alzheimer’s Day around the world. This is an international campaign aimed at raising awareness and challenge the common stigma that surrounds Alzheimer related dementia. Alzheimer’s is a progressive disease that impairs memory and other mental functions. It is the most common form of dementia that generalizes memory loss and loss of other essential cognitive abilities that are serious enough to interfere with an individual’s daily life.


MADIA fourth project meeting

MADIA fourth project meeting

The fourth project meeting of MADIA has started on 4th July 2018 in Brighton (UK), organized by the University of Brighton.

Development of a lab-on-a-chip method for rapid assay of Xylella fastidiosa

Development of a lab-on-a-chip method for rapid assay of Xylella fastidiosa

Researchers at CNR Nanotec, MADIA project partner, pubished an interesting study on Development of a lab-on-a-chip method for rapid assay of Xylella fastidiosa.

Read more


MADIA project at the Hannover Messe 2018

MADIA project at the Hannover Messe 2018

Scriba Nanotecnologie has presented MADIA project at the HANNOVER MESSE 2018, one of the world's largest industrial trade fairs that took place in Hannover from 23th to 27th April.

Read more



MADIA workshop

MADIA workshop

The urgent need for early diagnosis in neurodegenerative disease, namely Alzheimer's s disease and Parkinson's disease, calls for multidisciplinary approach in order to tailor diagnostic and therapeutical tools on different diseases presentation at the early stage of the diseases.

Read more


Pharma giant ending Alzheimer's research

Pharma giant ending Alzheimer's research

"The US-based pharmaceutical giant said it would be ending its neuroscience discovery programmes following a review, and 300 jobs would be lost. The Alzheimer's Society called the news "disappointing" and a "heavy blow" to those living with dementia. "

Read more


Scientists uncover the structure of tau filaments from Alzheimer's disease

Scientists uncover the structure of tau filaments from Alzheimer's disease

Researchers at the MRC Laboratory of Molecular Biology (LMB) have, for the first time, revealed the atomic structures of one of the two types of the abnormal filaments which lead to Alzheimer's disease.

Read more


MADIA 6 Months project meeting

MADIA 6 Months project meeting

The 6 Months project meeting of MADIA was held on 6-7 July 2017 in Santiago de Compostela (Spain), organized by Universidad De Santiago De Compostela (USC) and Servizo Galego De Saúde (SERGAS).

THIS WEBSITE STORES AND GAIN ACCESS TO INFORMATION ALREADY STORED IN USER’S DEVICE BY THE USAGE OF COOKIES. CONSENT OR LACK OF CONSENT FOR THE USAGE OF COOKIES MAY BY EXPRESSED BY A BROWSER CONFIGURATION